MCL1 and prostate carcinoma: Increased MCL-1 expression and BAD phosphorylation were identified as target molecules responsible for apoptosis inhibition in prostate cancer cells by ADRB2/PKA pathway, whereas the effectors responsible for accelerated migration await further investigation [28,29].